enGene Holdings- Warrants (31/10/2028) Overview

enGene Holdings- Warrants (31/10/2028) Research & Development

Research & Development expenses for ENGNW.

Quarterly R&D Expenses

$22.25M

↑ 11.42% YoY

As of Jan 31, 2026

Annual R&D Expenses (TTM)

$96.76M

↑ 83.78% YoY

Trailing 12 months ending Jan 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin